Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Oct;39(10):977-83.
doi: 10.1007/s11745-004-1319-y.

Inhibitory action of conjugated C18-fatty acids on DNA polymerases and DNA topoisomerases

Affiliations
Comparative Study

Inhibitory action of conjugated C18-fatty acids on DNA polymerases and DNA topoisomerases

Yoshiyuki Mizushina et al. Lipids. 2004 Oct.

Abstract

We reported previously that unsaturated linear-chain FA of the cis-configuration with a C18-hydrocarbon chain such as linoleic acid (18:2delta9c,12c) could potently inhibit the activities of mammalian DNA polymerases and DNA topoisomerases, but their saturated forms could not. There are chemically two classes of unsaturated FA, normal and conjugated, but only the conjugated forms show potent antitumor activity. In this report, we study the inhibitory effects of chemically synthesized conjugated C18-FA on mammalian DNA polymerases and DNA topoisomerases as compared with normal unsaturated FA. The conjugated alpha-eleostearic acid (18:3delta9c,11t, 13t) was the strongest of all the FA tested. For the inhibition, the conjugated form is crucially important. The energy-minimized 3-D structures of the FA were calculated, and both a length of less than 20 A and a width of 8.13-9.24 A in the C18-FA structure were found to be important for enzyme inhibition. The 3-D structure of the active site of both DNA polymerases and topoisomerases must have had a pocket to join alpha-eleostearic acid, and this pocket was 12.03 A long and 9.24 A wide.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Carcinogenesis. 2004 Aug;25(8):1417-25 - PubMed
    1. Cancer Lett. 1997 Jun 24;116(2):121-30 - PubMed
    1. Seikagaku. 2002 Mar;74(3):244-51 - PubMed
    1. Anticancer Res. 1995 Jul-Aug;15(4):1241-6 - PubMed
    1. Cancer Res. 1991 Nov 15;51(22):6118-24 - PubMed

Publication types

LinkOut - more resources